Jeffrey D Yoder

US Patent:

20090232824, Sep 17, 2009

Filed:

Apr 15, 2009

Appl. No.:

12/423855

Inventors:

GARY W. LITMAN - Gulfport FL, US
Noel A. Hawke - Durham NC, US
Jeffrey A. Yoder - St. Petersburg FL, US
Donna D. Eason - Bradenton FL, US

Assignee:

University of South Florida - Tampa FL

International Classification:

A61K 39/395
A61K 39/00
C07K 14/00
C07K 16/00

US Classification:

4241391, 4241851, 530350, 5303879

Abstract:

The subject invention provides polynucleotide sequences, designated BIVM, and transcriptional/translational products obtained from the polynucleotide sequences of the invention. The subject invention also provides polynucleotide and polypeptide sequences provided by SEQ ID NOs: 1-28. Also provided are methods of detecting the presence of BIVM nucleic acids or polypeptides in samples suspected of containing BIVM genes, BIVM transcriptional products, or BIVM translational products. These methods are also useful for the detection of BIVM orthologs. Other embodiments provide polypeptide and/or nucleic acid vaccines for the induction of an immune response to in an individual. Kits for detecting the presence of BIVM genes, orthologs thereof, BIVM polypeptides, or BIVM transcriptional products are also provided.

US Patent:

20060205689, Sep 14, 2006

Filed:

May 2, 2006

Appl. No.:

11/415536

Inventors:

Gary Litman - Gulfport FL, US
Noel Hawke - Durham NC, US
Jeffrey Yoder - St. Petersburg FL, US
Donna Eason - Bradenton FL, US

Assignee:

University of South Florida - Tampa FL

International Classification:

A61K 31/70
C12P 19/34
A01N 43/04

US Classification:

514044000, 435091100

Abstract:

The subject invention provides polynucleotide sequences, designated BIVM, and transcriptional/translational products obtained from the polynucleotide sequences of the invention. The subject invention also provides polynucleotide and polypeptide sequences provided by SEQ ID NOs:1-28. Also provided are methods of detecting the presence of BIVM nucleic acids or polypeptides in samples suspected of containing BIVM genes, BIVM transcriptional products, or BIVM translational products. These methods are also useful for the detection of BIVM orthologs. Other embodiments provide polypeptide and/or nucleic acid vaccines for the induction of an immune response to in an individual. Kits for detecting the presence of BIVM genes, orthologs thereof, BIVM polypeptides, or BIVM transcriptional products are also provided.